Mason M Silveira
Overview
    Explore the profile of Mason M Silveira including associated specialties, affiliations and a list of published articles.
          
  Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
  
  
  Snapshot
          Snapshot
              Articles
              15
            
            
              Citations
              107
            
            
              Followers
              0
            
  
  Related Specialties
          Related Specialties
  Top 10 Co-Authors
          Top 10 Co-Authors
  Published In
          
        
        
        
  Affiliations
        Affiliations
    Soon will be listed here.
  
  Recent Articles
          1.
        
    
    Hathaway B, Li A, Brodie H, Silveira M, Tremblay M, Seo Y, et al.
  
  
    Eur J Neurosci
    . 2024 Feb;
          59(7):1621-1637.
    
    PMID: 38369911
  
  
          Deficits in cost/benefit decision making is a critical risk factor for gambling disorder. Reward-paired cues may play an important role, as these stimuli can enhance risk preference in rats. Despite...
      
2.
        
    
    Hales C, Silveira M, Calderhead L, Mortazavi L, Hathaway B, Winstanley C
  
  
    Psychopharmacology (Berl)
    . 2024 Jan;
          241(5):947-962.
    
    PMID: 38172238
  
  
          Rationale: The rat cognitive effort task (rCET), a rodent model of cognitive rather than physical effort, requires animals to choose between an easy or hard visuospatial discrimination, with a correct...
      
3.
        
    
    Ferland J, Ellis R, Betts G, Silveira M, de Firmino J, Winstanley C, et al.
  
  
    JAMA Psychiatry
    . 2022 Nov;
          80(1):66-76.
    
    PMID: 36416863
  
  
          Importance: Although perceived as relatively harmless and nonaddictive, adolescent cannabis use significantly increases the likelihood of developing cannabis use disorder in adulthood, especially for high-potency cannabis. Risky decision-making is associated...
      
4.
        
    
    Silveira M, Wittekindt S, Ebsary S, Winstanley C
  
  
    Eur J Neurosci
    . 2020 Aug;
          53(3):852-860.
    
    PMID: 32810880
  
  
          Organisms must frequently evaluate the amount of effort to invest in pursuing future rewards. Despite explicit awareness of the potential benefits of cognitive work, individuals vary in their willingness to...
      
5.
        
    
    Hynes T, Ferland J, Feng T, Adams W, Silveira M, Tremblay M, et al.
  
  
    Behav Neurosci
    . 2020 Jun;
          134(4):309-322.
    
    PMID: 32525335
  
  
          Women and men can differ in their propensity to take risks and develop impulse control and addiction disorders. Sexual dimorphisms in behavioral control by the mesolimbic dopaminergic reward system may...
      
6.
        
    
    Silveira M, Wittekindt S, Mortazavi L, Hathaway B, Winstanley C
  
  
    J Psychopharmacol
    . 2020 Jan;
          34(4):452-466.
    
    PMID: 31913079
  
  
          Background: Individuals must frequently evaluate whether it is worth allocating cognitive effort for desired outcomes. Motivational deficits are a common feature of psychiatric illness such as major depression. Selective serotonin...
      
7.
        
    
    Silveira M, Tremblay M, Winstanley C
  
  
    Neuropharmacology
    . 2018 May;
          137:322-331.
    
    PMID: 29778947
  
  
          Cognitive effort is a ubiquitous process, yet surprisingly little is known about the brain mechanisms responsible for evaluating it. Here, we utilize the rat Cognitive Effort Task (rCET) to probe...
      
8.
        
    
    Adams W, Vonder Haar C, Tremblay M, Cocker P, Silveira M, Kaur S, et al.
  
  
    eNeuro
    . 2017 Aug;
          4(4).
    
    PMID: 28791332
  
  
          Deep brain stimulation of the subthalamic nucleus (STN-DBS) can improve the motor symptoms of Parkinson's disease (PD) and negate the problematic side effects of dopamine replacement therapy. Although there is...
      
9.
        
    
    Silveira M, Adams W, Morena M, Hill M, Winstanley C
  
  
    J Psychiatry Neurosci
    . 2017 Mar;
          42(2):131-138.
    
    PMID: 28245177
  
  
          Background: Acceptance of cannabis use is growing. However, prolonged use is associated with diminished psychosocial outcomes, potentially mediated by drug-induced cognitive impairments. Δ-Tetrahydrocannabinol (THC) is the main psychoactive ingredient in...
      
10.
        
    
    Silveira M, Arnold J, Laviolette S, Hillard C, Celorrio M, Aymerich M, et al.
  
  
    Neurosci Biobehav Rev
    . 2016 Sep;
          76(Pt B):380-395.
    
    PMID: 27639448
  
  
          Public opinion surrounding the recreational use and therapeutic potential of cannabis is shifting. This review describes new work examining the behavioural and neural effects of cannabis and the endocannabinoid system,...